GL1X · GenesisL1 explorer

Research workbench

Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations

Analyse Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5NBU
Type
protein
Length
370 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-1-antitrypsin
UniProt
P01009
Ligands
OXM
Pockets
3 · best druggability 0.51

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-1-antitrypsinprotein37030% helix, 31% strandP01009

Ligands and binding sites

  • OXM · Oxamic acid · ligand · 2 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1530.510.8816empty
21240.500.8027OXM
3540.300.7615empty

Compared structures

  • 5NBU · Crystal structure of native alpha-1-antitrypsin with seven stabilising mutations · the same entry in another collection · chain A against A, TM-score 1.00
  • P01009 · AlphaFold monomer V2.0 prediction for alpha-1-antitrypsin (P01009) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.